Thousands of bottles of a blood pressure medicine have been recalled across the United States after failing testing by the Food and Drug Administration (FDA).
Inventia Healthcare Limited, based in India, has withdrawn 13,567 bottles of its 25mg chlorthalidone tablets. The medicine is used to treat high blood pressure and the recalled bottles contain 100 tablets each.
The affected batch is marked RISA24002 and carries an expiry date of April 2027. The FDA said the tablets failed dissolution specifications, meaning they may not break down properly after being taken and could affect how the active ingredient is released.
The recall applies nationwide and was classified as Class II. The FDA uses that category when exposure to a product could cause temporary or medically reversible health problems, or when the likelihood of serious harm is considered remote.
What patients should check
Patients prescribed chlorthalidone should check the batch number and expiry date on their bottle. Anyone with a matching pack should contact a pharmacist or healthcare professional for advice before making any changes to their treatment.
Chlorthalidone is a diuretic commonly prescribed for high blood pressure. It can also be used to reduce fluid retention linked to certain heart, kidney and liver conditions.
The latest action follows a separate recall by Inventia in June involving about 11,460 bottles of chlorthalidone. That earlier recall also concerned tablets that failed dissolution testing.
